Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 9, 2015, Pages 1928-1939

  Magalhães, Ana ^a,b   Marcos Pinto, Ricardo ^b,c,d   Nairn, Alison V ^e   dela Rosa, Mitche ^e   Ferreira, Rui M ^a,b   Junqueira Neto, Susana ^a,b   Freitas, Daniela ^a,b   Gomes, Joana ^a,b   Oliveira, Patrícia ^a,b   Santos, Marta R ^b   Marcos, Nuno T ^a,b,f   Xiaogang, Wen ^g,h   Figueiredo, Céu ^a,b,d   Oliveira, Carla ^a,b,d   Dinis Ribeiro, Mário ^b,d,i   Carneiro, Fátima ^a,b,d,g   Moremen, Kelley W ^e   David, Leonor ^a,b,d   Reis, Celso A ^a,b,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Centro Hospitalar Universitario do Porto   (Portugal)

^d University of Porto   (Portugal)

^e University of Aveiro ^*  (United States)

^f UNIVERSITY OF AVEIRO   (Portugal)

^g Centro Hospitalar Universitário de São João   (Portugal)

^h Centro Hospitalar Vila Nova de Gaia/Espinho   (Portugal)

ⁱ Gastroenterology Department   (Portugal)

Author keywords

Chronic infection; Glycophenotype; Helicobacter pylori; Sialic acid binding adhesin

Indexed keywords

BETA 1,3 GALACTOSYLTRANSFERASE 5; BETA 1,3 N ACETYLGLUCOSAMINYLTRANSFERASE 5; BIOLOGICAL MARKER; FUCOSYLTRANSFERASE 3; GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN BABA; OUTER MEMBRANE PROTEIN BABB; OUTER MEMBRANE PROTEIN SABA; SIALOADHESIN; SIALYL LEWIS X ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL LOAD; BACTERIUM ADHERENCE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; GASTRIC GLYCOSYLATION; GASTRIC MUCOSA; GASTRITIS; GENE EXPRESSION REGULATION; GLYCOPHENOTYPE; GLYCOSYLATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIALYLATION; SIGNAL TRANSDUCTION; STOMACH FUNCTION; STOMACH PARAMETERS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84940455366     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.07.001     Document Type: Article

References (62)

1. Correa P., Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007, 133:659-672.
2. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 11 2013, International Agency for Researh on Cancer, Lyon, France.
3. Wroblewski L.E., Peek R.M., Wilson K.T. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev. 2010, 23:713-739.
4. Hatakeyama M. Helicobacter pylori CagA and gastric Cancer: a paradigm for hit-and-run carcinogenesis. Cell Host and Microbe 2014, 15:306-316.
5. Blaser M.J., Perez-Perez G.I., Kleanthous H., Cover T.L., Peek R.M., Chyou P.H., Stemmermann G.N., Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995, 55:2111-2115.
6. Enroth H., Kraaz W., Engstrand L., Nyrén O., Rohan T. Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev. 2000, 9:981-985.
7. Magalhães A., Ismail M.N., Reis C.A. Sweet receptors mediate the adhesion of the gastric pathogen Helicobacter pylori: glycoproteomic strategies. Expert Rev. Proteomics 2010, 7:307-310.
8. Azevedo M., Eriksson S., Mendes N., Serpa J., Figueiredo C., Resende L.P., Ruvoën-Clouet N., Haas R., Borén T., Pendu J.L., David L. Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J. Pathol. 2008, 215:308-316.
9. Ilver D., Arnqvist A., Ogren J., Frick I.-M., Kersulyte D., Incecik E.T., Berg D.E., Covacci A., Engstrand L., Boren T. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998, 279:373-377.
10. Magalhaes A., Gomes J., Ismail M.N., Haslam S.M., Mendes N., Osorio H., David L., Le Pendu J., Haas R., Dell A., Boren T., Reis C.A. Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa. Glycobiology 2009, 19:1525-1536.
11. Mahdavi J., Sonden B., Hurtig M., Olfat F.O., Forsberg L., Roche N., Angstrom J., Larsson T., Teneberg S., Karlsson K.-A., Altraja S., Wadstrom T., Kersulyte D., Berg D.E., Dubois A., Petersson C., Magnusson K.-E., Norberg T., Lindh F., Lundskog B.B., Arnqvist A., Hammarstrom L., Boren T. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002, 297:573-578.
12. Bäckström A., Lundberg C., Kersulyte D., Berg D.E., Borén T., Arnqvist A. Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:16923-16928.
13. Rossez Y., Gosset P., Boneca I.G., Magalhães A., Ecobichon C., Reis C.A., Cieniewski-Bernard C., Joncquel Chevalier Curt M., Léonard R., Maes E., Sperandio B., Slomianny C., Sansonetti P.J., Michalski J.C., Robbe-Masselot C. The LacdiNAc-specific adhesin LabA mediates adhesion of Helicobacter pylori to human gastric mucosa. J. Infect. Dis. 2014, 210:1286-1295.
14. Ishijima N., Suzuki M., Ashida H., Ichikawa Y., Kanegae Y., Saito I., Borén T., Haas R., Sasakawa C., Mimuro H. BabA-mediated adherence is a potentiator of the Helicobacter pylori Type IV secretion system activity. J. Biol. Chem. 2011, 286:25256-25264.
15. Brandt S., Kwok T., Hartig R., König W., Backert S. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9300-9305.
16. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., DiStefano P.S., Sansonetti P.J., Labigne A., Bertin J., Philpott D.J., Ferrero R.L. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 2004, 5:1166-1174.
17. Ota H., Nakayama J., Momose M., Hayama M., Akamatsu T., Katsuyama T., Graham D.Y., Genta R.M. Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch. 1998, 433:419-426.
18. Pinho S.S., Carvalho S., Marcos-Pinto R., Magalhães A., Oliveira C., Gu J., Dinis-Ribeiro M., Carneiro F., Seruca R., Reis C.A. Gastric cancer: adding glycosylation to the equation. Trends Mol. Med. 2013, 19:664-676.
19. Colomb F., Krzewinski-Recchi M.A., El Machhour F., Mensier E., Jaillard S., Steenackers A., Harduin-Lepers A., Lafitte J.J., Delannoy P., Groux-Degroote S. TNF regulates sialyl-Lewisx and 6-sulfo-sialyl-Lewisx expression in human lung through up-regulation of ST3GAL4 transcript isoform BX. Biochimie 2012, 94:2045-2053.
20. Colomb F., Vidal O., Bobowski M., Krzewinski-Recchi M.A., Harduin-Lepers A., Mensier E., Jaillard S., Lafitte J.J., Delannoy P., Groux-Degroote S. TNF induces the expression of the sialyltransferase ST3Gal IV in human bronchial mucosa via MSK1/2 protein kinases and increases FliD/sialyl-Lewis(x)-mediated adhesion of Pseudomonas aeruginosa. Biochem. J. 2014, 457:79-87.
21. Delmotte P., Degroote S., Lafitte J.-J., Lamblin G., Perini J.-M., Roussel P. Tumor necrosis factor α increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa. J. Biol. Chem. 2002, 277:424-431.
22. Marcos N., Magalhães A., Ferreira B., Oliveira M., Carvalho A., Mendes N., Gilmartin T., Head S., Figueiredo C., David L., Santos-Silva F., Reis C. Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x. J. Clin. Invest. 2008, 118:2325-2336.
23. Marcos-Pinto R., Carneiro F., Dinis-Ribeiro M., Wen X., Lopes C., Figueiredo C., Machado J.C., Ferreira R.M., Reis C.A., Ferreira J., Pedroto I., Areias J. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment. Pharmacol. Ther. 2012, 35:1451-1459.
24. Figueiredo C., Machado J.C., Pharoah P., Seruca R., Sousa S., Carvalho R., Capelinha A.F., Quint W., Caldas C., van Doorn L.-J., Carneiro F., Sobrinho-Simões M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 2002, 94:1680-1687.
25. Lofling J., Holgersson J. Core saccharide dependence of sialyl Lewis X biosynthesis. Glycoconj. J. 2009, 26:33-40.
26. Nairn A.V., dela Rosa M., Moremen K.W. Transcript analysis of stem cells. Methods Enzymol 2010, vol. 479:73-91. Academic Press. F. Minoru (Ed.).
27. Flicek P., Amode M.R., Barrell D., Beal K., Billis K., Brent S., Carvalho-Silva D., Clapham P., Coates G., Fitzgerald S., Gil L., Girón C.G., Gordon L., Hourlier T., Hunt S., Johnson N., Juettemann T., Kähäri A.K., Keenan S., Kulesha E., Martin F.J., Maurel T., McLaren W.M., Murphy D.N., Nag R., Overduin B., Pignatelli M., Pritchard B., Pritchard E., Riat H.S., Ruffier M., Sheppard D., Taylor K., Thormann A., Trevanion S.J., Vullo A., Wilder S.P., Wilson M., Zadissa A., Aken B.L., Birney E., Cunningham F., Harrow J., Herrero J., Hubbard T.J.P., Kinsella R., Muffato M., Parker A., Spudich G., Yates A., Zerbino D.R., Searle S.M.J. Ensembl 2014. Nucleic Acids Res. 2014, 42:D749-D755.
28. Farré D., Roset R., Huerta M., Adsuara J.E., Roselló L., Albà M.M., Messeguer X. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003, 31:3651-3653.
29. Magalhães A., Marcos N.T., Carvalho A.S., David L., Figueiredo C., Bastos J., David G., Reis C.A. Helicobacter pylori cag pathogenicity island-positive strains induce syndecan-4 expression in gastric epithelial cells 2009.
30. Ferreira R.M., Machado J.C., Letley D., Atherton J.C., Pardo M.L., Gonzalez C.A., Carneiro F., Figueiredo C. A novel method for genotyping the Helicobacter pylori vacA intermediate region directly in gastric biopsy specimens. J. Clin. Microbiol. 2012, 50:3983-3989.
31. Odenbreit S., Swoboda K., Barwig I., Ruhl S., Borén T., Koletzko S., Haas R. Outer membrane protein expression profile in Helicobacter pylori clinical isolates. Infect. Immun. 2009, 77:3782-3790.
32. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011, 25:1010-1022.
33. Gomes J., Magalhães A., Carvalho A.S., Hernandez G.E., Papp S.L., Head S.R., Michel V., David L., Gärtner F., Touati E., Reis C.A. Glycophenotypic alterations induced by Pteridium aquilinum in mice gastric mucosa: synergistic effect with Helicobacter pylori infection. PLoS ONE 2012, 7. (e38353).
34. Lindén S., Mahdavi J., Semino-Mora C., Olsen C., Carlstedt I., Borén T., Dubois A. Role of ABO secretor status in mucosal innate immunity and H. pylori infection. PLoS Pathog. 2008, 4:6-13.
35. Ohno T., Vallström A., Rugge M., Ota H., Graham D.Y., Arnqvist A., Yamaoka Y. Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J. Infect. Dis. 2011, 203:726-735.
36. Gagneux P., Cheriyan M., Hurtado-Ziola N., van der Linden E.C.M.B., Anderson D., McClure H., Varki A., Varki N.M. Human-specific regulation of α2-6-linked sialic acids. J. Biol. Chem. 2003, 278:48245-48250.
37. Togayachi A., Akashima T., Ookubo R., Kudo T., Nishihara S., Iwasaki H., Natsume A., Mio H., Inokuchi J.-i., Irimura T., Sasaki K., Narimatsu H. Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide β1,3-N-acetylglucosaminyltransferase (β3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J. Biol. Chem. 2001, 276:22032-22040.
38. Henion T.R., Zhou D., Wolfer D.P., Jungalwala F.B., Hennet T. Cloning of a mouse β1,3N-acetylglucosaminyltransferase GlcNAc(β1,3)Gal(β1,4)Glc-ceramide synthase gene encoding the key regulator of Lacto-series glycolipid biosynthesis. J. Biol. Chem. 2001, 276:30261-30269.
39. Togayachi A., Kozono Y., Ikehara Y., Ito H., Suzuki N., Tsunoda Y., Abe S., Sato T., Nakamura K., Suzuki M., Goda H.M., Ito M., Kudo T., Takahashi S., Narimatsu H. Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11900-11905.
40. Holmes E.H., Ostrander G.K., Clausen H., Graem N. Oncofetal expression of Lex carbohydrate antigens in human colonic adenocarcinomas. Regulation through type 2 core chain synthesis rather than fucosylation. J. Biol. Chem. 1987, 262:11331-11338.
41. Holmes E.H., Hakomori S., Ostrander G.K. Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed beta 1-3N-acetylglucosaminyltransferase. J. Biol. Chem. 1987, 262:15649-15658.
42. Lin C.-H., Fan Y.-Y., Chen Y.-Y., Wang S.-H., Chen C.-I., Yu L.-C., Khoo K.-H. Enhanced expression of β3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. Glycobiology 2009, 19:418-427.
43. Salvini R., Bardoni A., Valli M., Trinchera M. β1,3-Galactosyltransferase β3Gal-T5 Acts on the GlcNAcβ1→3Galβ1→4GlcNAcβ1→R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas. J. Biol. Chem. 2001, 276:3564-3573.
44. Mare L., Trinchera M. Suppression of β1,3galactosyltransferase β3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans. Eur. J. Biochem. 2004, 271:186-194.
45. Harduin-Lepers A., Krzewinski-Recchi M.A., Colomb F., Foulquier F., Groux-Degroote S., Delannoy P. Sialyltransferases functions in cancers. Front. Biosci. (Elite Ed.) 2012, 4:499-515.
46. Roche N., Ångström J., Hurtig M., Larsson T., Borén T., Teneberg S. Helicobacter pylori and complex gangliosides. Infect. Immun. 2004, 72:1519-1529.
47. Roche N., Larsson T., Ångström J., Teneberg S. Helicobacter pylori-binding gangliosides of human gastric adenocarcinoma. Glycobiology 2001, 11:935-944.
48. Wada A., Hasegawa M., Wong P.-F., Shirai E., Shirai N., Tan L.-J., Llanes R., Hojo H., Yamasaki E., Ichinose A., Ichinose Y., Senba M. Direct binding of gangliosides to Helicobacter pylori vacuolating cytotoxin (VacA) neutralizes its toxin activity. Glycobiology 2010, 20:668-678.
49. Aspholm M., Olfat F.O., Nordén J., Sondén B., Lundberg C., Sjostrom R., Altraja S., Odenbreit S., Haas R., Wadstrom T., Engstrand L., Semino-Mora C., Liu H., Dubois A., Teneberg S., Arnqvist A., Borén T. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog. 2006, 2:e110.
50. Dohi T., Kawamura Y.I. Incomplete synthesis of the Sda/Cad blood group carbohydrate in gastrointestinal cancer. Biochim. Biophys. Acta 2008, 1780:467-471.
51. Groux-Degroote S., Wavelet C., Krzewinski-Recchi M.A., Portier L., Mortuaire M., Mihalache A., Trinchera M., Delannoy P., Malagolini N., Chiricolo M., Dall'Olio F., Harduin-Lepers A. B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract. Int. J. Biochem. Cell Biol. 2014, 53:442-449.
52. Kreisman L.S., Cobb B.A. Infection, inflammation and host carbohydrates: a Glyco-Evasion Hypothesis. Glycobiology 2012, 22:1019-1030.
53. Fox J.G., Wang T.C. Inflammation, atrophy, and gastric cancer. J. Clin. Invest. 2007, 117:60-69.
54. Basso D., Scrigner M., Toma A., Navaglia F., Di Mario F., Rugge M., Plebani M. Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int. J. Clin. Lab. Res. 1996, 26:207-210.
55. Noach L.A., Bosma N.B., Jansen J., Hoek F.J., van Deventer S.J., Tytgat G.N. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 1994, 29:425-429.
56. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-[kappa]B signaling pathways. Nat. Immunol. 2011, 12:695-708.
57. Lamb A., Chen L.-F. The many roads traveled by Helicobacter pylori to NF-κB activation. Gut Microbes 2010, 1:109-113.
58. Minami T., Miura M., Aird W.C., Kodama T. Thrombin-induced autoinhibitory factor, down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. J. Biol. Chem. 2006, 281:20503-20520.
59. Salama N.R., Hartung M.L., Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat. Rev. Microbiol. 2013, 11:385-399.
60. Aberg A., Gideonsson P., Vallstrom A., Olofsson A., Ohman C., Rakhimova L., Boren T., Engstrand L., Brannstrom K., Arnqvist A. A repetitive DNA element regulates expression of the Helicobacter pylori sialic acid binding adhesin by a rheostat-like mechanism. PLoS Pathog. 2014, 10. (e1004234).
61. Talarico S., Whitefield S.E., Fero J., Haas R., Salama N.R. Regulation of Helicobacter pylori adherence by gene conversion. Mol. Microbiol. 2012, 84:1050-1061.
62. Goodwin A.C., Weinberger D.M., Ford C.B., Nelson J.C., Snider J.D., Hall J.D., Paules C.I., Peek R.M., Forsyth M.H. Expression of the Helicobacter pylori adhesin SabA is controlled via phase variation and the ArsRS signal transduction system. Microbiology 2008, 154:2231-2240.